These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31131437)

  • 21. Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: the effect of the expression of cytochrome b(5) with recombinant P450 enzymes.
    Emoto C; Iwasaki K
    Xenobiotica; 2007 Sep; 37(9):986-99. PubMed ID: 17896325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochromes P450 and metabolism of xenobiotics.
    Anzenbacher P; Anzenbacherová E
    Cell Mol Life Sci; 2001 May; 58(5-6):737-47. PubMed ID: 11437235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.
    Gervasini G; Carrillo JA; Benitez J
    Clin Pharmacokinet; 2004; 43(11):693-706. PubMed ID: 15301574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
    Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
    Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P450 reaction phenotyping and inhibition and induction studies of pinostrobin in human liver microsomes and hepatocytes.
    Tan S; Dong Z; Zhang J; Efferth T; Fu Y; Hua X
    Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 28111763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Review: Effects of Macrolides on CYP450 Enzymes.
    Zhang L; Xu X; Badawy S; Ihsan A; Liu Z; Xie C; Wang X; Tao Y
    Curr Drug Metab; 2020; 21(12):928-937. PubMed ID: 32807049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling.
    Magliocco G; Rodieux F; Desmeules J; Samer CF; Daali Y
    Pediatr Res; 2020 Feb; 87(3):441-449. PubMed ID: 31600772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human.
    Grangeon A; Gravel S; Gaudette F; Turgeon J; Michaud V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():144-158. PubMed ID: 27978469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
    Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
    J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Software-aided cytochrome P450 reaction phenotyping and kinetic analysis in early drug discovery.
    Cece-Esencan EN; Fontaine F; Plasencia G; Teppner M; Brink A; Pähler A; Zamora I
    Rapid Commun Mass Spectrom; 2016 Jan; 30(2):301-10. PubMed ID: 26689160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.
    Streetman DS; Bertino JS; Nafziger AN
    Pharmacogenetics; 2000 Apr; 10(3):187-216. PubMed ID: 10803676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?
    Tanaka E; Kurata N; Yasuhara H
    J Clin Pharm Ther; 2003 Jun; 28(3):157-65. PubMed ID: 12795773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A High-Throughput (HTS) Assay for Enzyme Reaction Phenotyping in Human Recombinant P450 Enzymes Using LC-MS/MS.
    Li X; Suhar T; Glass L; Rajaraman G
    Curr Protoc Pharmacol; 2014 Mar; 64():9.18.1-10. PubMed ID: 26344210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotyping of CYP450 in human liver microsomes using the cocktail approach.
    Spaggiari D; Geiser L; Daali Y; Rudaz S
    Anal Bioanal Chem; 2014 Aug; 406(20):4875-87. PubMed ID: 24894520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism.
    Tracy TS; Chaudhry AS; Prasad B; Thummel KE; Schuetz EG; Zhong XB; Tien YC; Jeong H; Pan X; Shireman LM; Tay-Sontheimer J; Lin YS
    Drug Metab Dispos; 2016 Mar; 44(3):343-51. PubMed ID: 26681736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug metabolism in chronic renal failure.
    Pichette V; Leblond FA
    Curr Drug Metab; 2003 Apr; 4(2):91-103. PubMed ID: 12678690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of human cytochrome P-450 enzymes in the metabolism of xenobiotics].
    Monostory K; Vereczkey L
    Acta Pharm Hung; 1995 Sep; 65(5):147-56. PubMed ID: 7484161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards Predicting the Cytochrome P450 Modulation: From QSAR to Proteochemometric Modeling.
    Shoombuatong W; Prathipati P; Prachayasittikul V; Schaduangrat N; Malik AA; Pratiwi R; Wanwimolruk S; Wikberg JES; Gleeson MP; Spjuth O; Nantasenamat C
    Curr Drug Metab; 2017 Jul; 18(6):540-555. PubMed ID: 28322159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment.
    Snawder JE; Lipscomb JC
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):200-9. PubMed ID: 11067776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP-mediated clozapine interactions: how predictable are they?
    Chetty M; Murray M
    Curr Drug Metab; 2007 May; 8(4):307-13. PubMed ID: 17504220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.